首页> 美国卫生研究院文献>Acta Pharmacologica Sinica >Exosomes from Suxiao Jiuxin pill-treated cardiac mesenchymal stem cells decrease H3K27 demethylase UTX expression in mouse cardiomyocytes in vitro
【2h】

Exosomes from Suxiao Jiuxin pill-treated cardiac mesenchymal stem cells decrease H3K27 demethylase UTX expression in mouse cardiomyocytes in vitro

机译:苏消酒心丸治疗的大鼠心肌间充质干细胞外泌体降低小鼠心肌细胞H3K27脱甲基酶UTX表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Suxiao Jiuxin pill (SJP) is a traditional Chinese medicine for the treatment of acute coronary syndrome in China, which contains two principal components, tetramethylpyrazine (TMP) and borneol (BOR). Thus far, however, the molecular mechanisms underlying the beneficial effects of SJP on the cardiac microenvironment are unknown. Cardiac mesenchymal stem cells (C-MSCs) communicate with cardiomyocytes (CMs) through the release of microvesicles (exosomes) to restore cardiac homeostasis and elicit repair, in part through epigenetic regulatory mechanisms. In this study, we examined whether SJP treatment altered C-MSC-derived exosomes (SJP-Exos) to cause epigenetic chromatic remodeling in recipient CMs. C-MSC isolated from mouse hearts were pretreated with SJP (SJP-Exos), TMP (TMP-Exos) or BOR (BOR-Exos). Then, HL-1 cells, a mouse cardiomyocyte line, were treated with exosomes from control C-MSCs (Ctrl-Exos), SJP-Exos, TMP-Exos or BOR-Exos. Treatment with SJP-Exos significantly increased the protein levels of histone 3 lysine 27 trimethylation (H3K27me3), a key epigenetic chromatin marker for cardiac transcriptional suppression, in the HL-1 cells. To further explore the mechanisms of SJP-Exo-mediated H3K27me3 upregulation, we assessed the mRNA expression levels of key histone methylases (EZH1, EZH2 and EED) and demethylases (JMJD3 and UTX) in the exosome-treated HL-1 cells. Treatment with SJP-Exo selectively suppressed UTX expression in the recipient HL-1 cells. Furthermore, PCNA, an endogenous marker of cell replication, was significantly higher in SJP-Exo-treated HL-1 cells than in Ctrl-Exo-treated HL-1 cells. These results show that SJP-Exos increase cardiomyocyte proliferation and demonstrate that SJP can modulate C-MSC-derived exosomes to cause epigenetic chromatin remodeling in recipient cardiomyocytes; consequently, SJP-Exos might be used to promote cardiomyocyte proliferation.
机译:苏小酒救心丸(SJP)是中国治疗急性冠脉综合征的传统中药,它包含两个主要成分:川methyl嗪(TMP)和冰片(BOR)。然而,到目前为止,尚不清楚SJP对心脏微环境有益作用的分子机制。心肌间充质干细胞(C-MSC)通过释放微囊泡(外泌体)与心肌细胞(CMs)通讯,以部分地通过表观遗传调控机制恢复心脏稳态并引起修复。在这项研究中,我们检查了SJP处理是否会改变C-MSC衍生的外来体(SJP-Exos),以引起受体CM的表观遗传色重塑。从小鼠心脏分离的C-MSC可以用SJP(SJP-Exos),TMP(TMP-Exos)或BOR(BOR-Exos)进行预处理。然后,用来自对照C-MSC(Ctrl-Exos),SJP-Exos,TMP-Exos或BOR-Exos的外来体处理小鼠心肌细胞系HL-1细胞。用SJP-Exos进行处理可显着提高HL-1细胞中组蛋白3赖氨酸27三甲基化(H3K27me3)的蛋白质水平,H3K27me3是心脏转录抑制的关键表观遗传染色质标记。为了进一步探讨SJP-Exo介导的H3K27me3上调的机制,我们评估了外泌体处理的HL-1细胞中关键组蛋白甲基化酶(EZH1,EZH2和EED)和脱甲基酶(JMJD3和UTX)的mRNA表达水平。用SJP-Exo处理可以选择性抑制受体HL-1细胞中的UTX表达。此外,PCNA,一种细胞复制的内源性标志,在SJP-Exo处理的HL-1细胞中显着高于Ctrl-Exo处理的HL-1细胞。这些结果表明,SJP-Exos增加了心肌细胞的增殖,并表明SJP可以调节C-MSC衍生的外来体,导致受体心肌细胞的表观遗传染色质重塑。因此,SJP-Exos可用于促进心肌细胞增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号